Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 9, 2013, Pages 891-897

  Kamimura, M A ^a   Carrero, J J ^b   Canziani, M E F ^a   Watanabe, R ^a   Lemos, M M ^a   Cuppari, L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiovascular events; Chronic kidney disease; Computed tomography; Visceral obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL SUBCUTANEOUS FAT; ABNORMAL BLOOD PRESSURE; ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAYS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SEDENTARY LIFESTYLE;

ANGINA;

CARDIOVASCULAR EVENTS; CHRONIC KIDNEY DISEASE; COMPUTED TOMOGRAPHY; VISCERAL OBESITY;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884161004     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.06.004     Document Type: Article

References (37)

1. Foley R.N., Parfrey P.S., Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998, 9:S16-S23.
2. Collins A.J., Kasiske B., Herzog C., Chavers B., Foley R., Gilbertson D., et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2005, 45:A5-A7. S1-280.
3. Amann K., Gross M.L., Ritz E. Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target. J Am Soc Nephrol 2004, 15:1664-1666.
4. Zoccali C., Mallamaci F. Does adipose tissue have a key role in inflammation in CKD?. J Intern Med 2011, 269:407-409.
5. Lowrie E.G., Li Z., Ofsthun N., Lazarus J.M. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002, 62:1891-1897.
6. Leavey S.F., McCullough K., Hecking E., Goodkin D., Port F.K., Young E.W. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001, 16:2386-2394.
7. Kalantar-Zadeh K., Block G., Horwich T., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439-1444.
8. McDonald S.P., Collins J.F., Johnson D.W. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003, 14:2894-2901.
9. Kaizu Y., Tsunega Y., Yoneyama T., Sakao T., Hibi I., Miyaji K., et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 1998, 50:44-50.
10. de Mutsert R., Snijder M.B., van der Sman-de Beer F., Seidell J.C., Boeschoten E.W., Krediet R.T., et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007, 18:967-974.
11. Johansen K.L., Young B., Kaysen G.A., Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004, 80:324-332.
12. Beddhu S., Pappas L.M., Ramkumar N., Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003, 14:2366-2372.
13. Araujo I.C., Kamimura M.A., Draibe S.A., Canziani M.E., Manfredi S.R., Avesani C.M., et al. Nutritional parameters and mortality in incident hemodialysis patients. J Ren Nutr 2006, 16:27-35.
14. Agarwal R., Bills J.E., Light R.P. Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the "obesity paradox?". Hypertension 2010, 56:893-900.
15. World Health Organization Obesity: preventing and managing the global epidemic 1997 June 3-5, WHO Consultation on Obesity, Geneve.
16. Odamaki M., Furuya R., Ohkawa S., Yoneyama T., Nishikino M., Hishida A., et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999, 14:2427-2432.
17. Yamauchi T., Kuno T., Takada H., Nagura Y., Kanmatsuse K., Takahashi S. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 2003, 18:1842-1847.
18. Gohda T., Gotoh H., Tanimoto M., Sato M., Io H., Kaneko K., et al. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res 2008, 31:83-88.
19. Kaysen G.A., Kotanko P., Zhu F., Sarkar S.R., Heymsfield S.B., Kuhlmann M.K., et al. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr 2009, 19:357-364.
20. Kato A., Ishida J., Endo Y., Takita T., Furuhashi M., Maruyama Y., et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 2010, 26(6):1967-1976.
21. Sanches F.M., Avesani C.M., Kamimura M.A., Lemos M.M., Axelsson J., Vasselai P., et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008, 52:66-73.
22. Fernstrom A., Hylander B., Moritz A., Jacobsson H., Rossner S. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998, 18:166-171.
23. Choi S.J., Kim N.R., Hong S.A., Lee W.B., Park M.Y., Kim J.K., et al. Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int 2011, 31(1):67-73.
24. Velludo C.M., Kamimura M.A., Sanches F.M., Lemos M.M., Canziani M.E., Pupim L.B., et al. Prospective evaluation of waist circumference and visceral adipose tissue in patients with chronic kidney disease. Am J Nephrol 2010, 31(2):104-109.
25. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
26. Valdez R., Seidell J.C., Ahn Y.I., Weiss K.M. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. Int J Obes Relat Metab Disord 1993, 17:77-82.
27. National Kidney Foundation K/DOQI - Kidney Disease Outcome Quality Initiative, clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2001, 41(4):S1-70.
28. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
29. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
30. Elsayed E.F., Tighiouart H., Weiner D.E., Elsayed E.F., Tighiouart H., Weiner D.E., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 2008, 52:49-57.
31. Postorino M., Marino C., Tripepi G., Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009, 53:1265-1272.
32. Cordeiro A.C., Qureshi A.R., Stenvinkel P., Heimbürger O., Axelsson J., Bárány P., et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010, 25:562-568.
33. Carrero J.J., Cordeiro A.C., Lindholm B., Stenvinkel P. The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens 2010, 19:37-42.
34. Landau M., Kurella-Tamura M., Shlipak M.G., Kanaya A., Strotmeyer E., Koster A., et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 2011, 26(9):2814-2819.
35. Witasp A., Carrero J.J., Heimburger O., Lindholm B., Hammarqvist F., Stenvinkel P., et al. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. J Intern Med 2011, 269:410-419.
36. Roubicek T., Bartlova M., Krajickova J., Haluzikova D., Mraz M., Lacinova Z., et al. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition 2009, 25:762-768.
37. Teplan V., Vyhnanek F., Gurlich R., Haluzík M., Racek J., Vyhnankova I., et al. Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr 2010, 122:466-473.